Although not a primary aim of this study and despite the small number of patients, preliminary survival data indicated that OS was significantly better for responders (CR and PR) compared with nonresponders, and this difference was apparent for assessments made on the basis of RECIST- and WHO-based CT criteria, as well as FOB-based evaluation.
← all excerpts
Comparison of Symptom Score and Bronchoscopy-Based Assessment With Conventional Computed Tomography-Based Assessment of Response to Chemotherapy in Lung Cancer.
1
—
—